JonathanDanielSchoenfeldMDMPH

Attending Radiation Oncologist, Director of Head and Neck Radiation Oncology, Dana-Farber/Brigham and Women's Cancer Center; Associate Professor in Radiation Oncology Harvard Medical School

Join to view full profile

Dr. Schoenfeld is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Schoenfeld's full profile

Already have an account?

Office
75 Francis St
Department Of Radiation Oncology
Boston, MA 02115
Phone+1 617-632-3591

Education & Training

Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Radiation Oncology, 2009 - 2013
Harvard Medical SchoolClass of 2008, cum laude
University of CambridgeMPhil, 2002 - 2003
Harvard School of Public HealthMPH
Yale UniversityBS, summa cum laude

Certifications & Licensure

MA State Medical License 2010 - 2025
FL State Medical License 2020 - 2022
ME State Medical License 2020 - 2021
American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

Gates Cambridge Scholar Gates Cambridge Trust

Clinical Trials

Study Evaluating a Stereotactic Boost/Treatment for Recurrent or Metastatic Cancer of the Head and Neck Start of enrollment: 2015 Nov 01
Active, not recruiting
Phase 1
Window Study of Nivolumab With or Without Ipilimumab in Squamous Cell Carcinoma of the Oral Cavity Start of enrollment: 2016 Nov 01
Active, not recruiting
Phase 2
Targeting PD-1 Therapy Resistance With Focused High or High and Low Dose Radiation in SCCHN Start of enrollment: 2017 Jun 30
Active, not recruiting
Phase 2
Stereotactic Body Radiotherapy (SBRT) for Early Treatment of Oligometastatic Adenoid Cystic Carcinoma: The SOLAR Trial Start of enrollment: 2021 Dec 27
Recruiting
Not Applicable
Risk-adapted Therapy in HPV+ Oropharyngeal Cancer Using Circulating Tumor (ct)HPV DNA Profile - The ReACT Study Start of enrollment: 2021 Jul 02
Recruiting
Phase 2
Join now to see all

Publications & Presentations

PubMed

71 citations
Immune profiling of adenoid cystic carcinoma: PD-L2 Expression and Associations With Tumor Infiltrating Lymphocytes
Vishwajith Sridharan, Evisa Gjini, Xiaoyun Liao, Nicole G. Chau, Robert I. Haddad
Cancer Immunology Research. 2016-08-01
40 citations
Defining an inflamed tumor immunophenotype in recurrent, metastatic squamous cell carcinoma of the head and neck.
Glenn J. Hanna, Hongye Liu, Robert E. Jones, A. Bacay, Patrick H. Lizotte
Oral Oncology. 2017-04-01
110 citations
The Impact of Radiation Therapy on Lymphocyte Count and Survival in Metastatic Cancer Patients Receiving PD-1 Immune Checkpoint Inhibitors
Luke R.G. Pike, Andrew Bang, Brandon A. Mahal, Allison Taylor, Monica Krishnan
International Journal of Radiation Oncology, Biology, Physics. 2019-01-01

Lectures

A randomized phase II study of pembrolizumab with or without radiation in patients with recurrent or metastatic adenoid cystic carcinoma.
2019 ASCO Annual Meeting - 6/1/2019

Press Mentions

Study Identifies T-cell Populations That Predict Response to ImmunotherapyJuly 12th, 2022
Study Identifies T-cell Populations That Predict Response to ImmunotherapyJuly 11th, 2022
ECOG-ACRIN Research Highlights at ASCO 2022May 27th, 2022
Join now to see all